Showing results (301-310 of 617) with videos related to
Sort By:
Pageof 62
Clinical Pharmacology and Therapeutics|November 4, 2011
Cannabinoid-opioid interaction in chronic painD I Abrams, P Couey, S B Shade, et al.Clinical Cardiology|October 12, 2011
Cardiology Rx for Change: improving clinical attention to tobacco use and secondhand smoke exposure in cardiologyJudith J Prochaska, Neal L Benowitz, Stanton A Glantz, et al.Clinical Pharmacology and Therapeutics|June 1, 1984
Blood cotinine levels as indicators of smoking treatment outcomeS M Hall, R I Herning, R T Jones, et al.Psychopharmacology|May 1, 1994
A low dose of subcutaneous nicotine improves information processing in non-smokersJ Le Houezec, R Halliday, N L Benowitz, et al.American Journal of Epidemiology|February 27, 2007
Urine nicotine metabolites and smoking behavior in a multiracial/multiethnic national sample of young adultsDenise B Kandel, Mei-Chen Hu, Christine Schaffran, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 17, 2007
Cotinine levels in relation to smoking behavior and addiction in young adolescent smokersMark L Rubinstein, Pamela J Thompson, Neal L Benowitz, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 22, 2010
Urine menthol as a biomarker of mentholated cigarette smokingNeal L Benowitz, Katherine M Dains, Delia Dempsey, et al.Chemical Research in Toxicology|October 16, 2013
Nicotelline: a proposed biomarker and environmental tracer for particulate matter derived from tobacco smokePeyton Jacob, Maciej L Goniewicz, Christopher M Havel, et al.Pharmacogenetics and Genomics|April 2, 2016
Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activityNeal L Benowitz, Gideon St Helen, Delia A Dempsey, et al.Pageof 62